It can be concluded that C(-104)T polymorphism in the regulatory region of Aldose Reductase (ALR2) gene was the risk factor for DR among T2DM patients in Bali, Indonesia. This evidence concerns the gene AKR1B1 and type 2 diabetes mellitus.